200 related articles for article (PubMed ID: 25398888)
1. Socioeconomic inequalities in quality of care and outcomes among patients with acute coronary syndrome in the modern era of drug eluting stents.
Yong CM; Abnousi F; Asch SM; Heidenreich PA
J Am Heart Assoc; 2014 Nov; 3(6):e001029. PubMed ID: 25398888
[TBL] [Abstract][Full Text] [Related]
2. Racial Differences in Quality of Care and Outcomes After Acute Coronary Syndrome.
Yong CM; Ungar L; Abnousi F; Asch SM; Heidenreich PA
Am J Cardiol; 2018 Jun; 121(12):1489-1495. PubMed ID: 29655881
[TBL] [Abstract][Full Text] [Related]
3. Survival benefit from recent changes in management of men and women with ST-segment elevation myocardial infarction treated with percutaneous coronary interventions.
Zandecki Ł; Sadowski M; Janion M; Kurzawski J; Gierlotka M; Poloński L; Gąsior M
Cardiol J; 2019; 26(5):459-468. PubMed ID: 29924379
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous coronary intervention for acute coronary syndrome due to graft failure: use of bare-metal and drug-eluting stents and subsequent long-term clinical outcome.
Harskamp RE; Kuijt WJ; Damman P; Beijk MA; Grundeken MJ; Woudstra P; Tijssen JG; de Winter RJ
Catheter Cardiovasc Interv; 2014 Feb; 83(2):203-9. PubMed ID: 22508617
[TBL] [Abstract][Full Text] [Related]
5. Sustained sex-based treatment differences in acute coronary syndrome care: Insights from the American Heart Association Get With The Guidelines Coronary Artery Disease Registry.
Udell JA; Fonarow GC; Maddox TM; Cannon CP; Frank Peacock W; Laskey WK; Grau-Sepulveda MV; Smith EE; Hernandez AF; Peterson ED; Bhatt DL;
Clin Cardiol; 2018 Jun; 41(6):758-768. PubMed ID: 29521450
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome.
Jiang M; You JHS
Clin Cardiol; 2017 Oct; 40(10):789-796. PubMed ID: 28683175
[TBL] [Abstract][Full Text] [Related]
7. Borderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry.
Siudak Z; Dziewierz A; Rakowski T; Żmudka K; Legutko J; Bartuś S; Dragan J; Zasada W; Tokarek T; Kułaga T; Partyka Ł; Dudek D
Catheter Cardiovasc Interv; 2014 Feb; 83(3):436-42. PubMed ID: 24038740
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
[TBL] [Abstract][Full Text] [Related]
9. Predictors and variability of drug-eluting vs bare-metal stent selection in contemporary percutaneous coronary intervention: Insights from the PRISM study.
Shafiq A; Gosch K; Amin AP; Ting HH; Spertus JA; Salisbury AC
Clin Cardiol; 2017 Aug; 40(8):521-527. PubMed ID: 28300284
[TBL] [Abstract][Full Text] [Related]
10. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention.
Loncar G; Barthelemy O; Berman E; Kerneis M; Petroni T; Payot L; Choussat R; Silvain J; Collet JP; Helft G; Montalescot G; Le Feuvre C
Arch Cardiovasc Dis; 2015 Nov; 108(11):554-62. PubMed ID: 26184868
[TBL] [Abstract][Full Text] [Related]
11. Temporal Trends Analysis of the Characteristics, Management, and Outcomes of Women With Acute Coronary Syndrome (ACS): ACS Israeli Survey Registry 2000-2016.
Porter A; Paradkar A; Goldenberg I; Shlomo N; Cohen T; Kornowski R; Eisen A
J Am Heart Assoc; 2020 Jan; 9(1):e014721. PubMed ID: 31852425
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes after treating acute coronary syndrome patients with a drug-eluting stent: results from REWARDS-EMI (Endeavor for Myocardial Infarction Registry).
Dvir D; Barbash IM; Torguson R; Badr S; Sardi GL; Laynez-Carnicero A; Ben-Dor I; Satler LF; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2013; 14(3):128-33. PubMed ID: 23642502
[TBL] [Abstract][Full Text] [Related]
13. Procedural Volume and Outcomes After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction in Kerala, India: Report of the Cardiological Society of India-Kerala Primary Percutaneous Coronary Intervention Registry.
Jabir A; Mathew A; Zheng Y; Westerhout C; Viswanathan S; Sebastian P; Kumar P; Bangalore S; Bainey KR; Welsh R
J Am Heart Assoc; 2020 Jun; 9(12):e014968. PubMed ID: 32476563
[TBL] [Abstract][Full Text] [Related]
14. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
[TBL] [Abstract][Full Text] [Related]
15. Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes.
Brener SJ; Cristea E; Kirtane AJ; McEntegart MB; Xu K; Mehran R; Stone GW
JACC Cardiovasc Interv; 2013 Jan; 6(1):36-43. PubMed ID: 23266233
[TBL] [Abstract][Full Text] [Related]
16. Gender disparity in the use of drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction.
Iyanoye A; Moreyra AE; Swerdel JN; Gandhi SK; Cabrera J; Cosgrove NM; Kostis JB;
Catheter Cardiovasc Interv; 2015 Aug; 86(2):221-8. PubMed ID: 25645156
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and resource utilization in ST-elevation myocardial infarction in the United States: evidence for socioeconomic disparities.
Agarwal S; Garg A; Parashar A; Jaber WA; Menon V
J Am Heart Assoc; 2014 Nov; 3(6):e001057. PubMed ID: 25399775
[TBL] [Abstract][Full Text] [Related]
18. Comparison of long-term outcomes in STEMI and NSTE-ACS after coronary stent placement: an analysis in a real world BMS and DES population.
van Leeuwen MA; Daemen J; van Mieghem NM; de Boer SP; Boersma E; van Geuns RJ; Zijlstra F; van Domburg RT; Serruys PW;
Int J Cardiol; 2013 Sep; 167(5):2082-7. PubMed ID: 22664371
[TBL] [Abstract][Full Text] [Related]
19. Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome).
Fosbøl EL; Ju C; Anstrom KJ; Zettler ME; Messenger JC; Waksman R; Effron MB; Baker BA; Cohen DJ; Peterson ED; Wang TY
Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27789517
[TBL] [Abstract][Full Text] [Related]
20. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR.
Sarno G; Lagerqvist B; Nilsson J; Frobert O; Hambraeus K; Varenhorst C; Jensen UJ; Tödt T; Götberg M; James SK
J Am Coll Cardiol; 2014 Jul; 64(1):16-24. PubMed ID: 24998123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
